Kaplan-Meier Estimated 3-Year Recurrence-Free Survival Curves.
- Weiya Z. Wysham (335681)
- Paulette Mhawech-Fauceglia (226809)
- Hong Li (20183)
- Laura Hays (335682)
- Suzanna Syriac (335683)
- Tijana Skrepnik (335684)
- Jay Wright (335685)
- Nupur Pande (335686)
- Maureen Hoatlin (335688)
- Tanja Pejovic (241749)
Publication date
February 2013
DOIAbstract
<p>Kaplan-Meier estimated 3-year recurrence-free survival curves. <b>A:</b> No difference in recurrence-free survival when each of the 5 mutually exclusive groups by expression of PARP, FANCD2, and P53 were examined independently. <b>B:</b> Patients positive for all three PARP, FANCD2, and P53 had lower recurrence-free survival compared to patients not positive for all three.</p
Add to ORKG